Search - tctmd.com

Displaying 21 - 31 of 31

Sort: Relevancy | Date

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Industry News

FDA Advisory Committee Recommends Against Approval of Oral Anticoagulant XARELTO® to Reduce the Risk of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

May 23, 2012

News Industry News

Low CV Event Rate Prompts Closure of Prasugrel Trial

November 09, 2011

News Industry News

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

November 09, 2011

News Industry News

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

November 08, 2011

News Industry News

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery

November 08, 2011

News Industry News

Axxess Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Five Years

November 07, 2011

News Industry News

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System

November 06, 2011

News Industry News

Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study

August 15, 2011

News Industry News

FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US

July 20, 2011

News Industry News

2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery

March 08, 2011

Advertisement

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

FDA Advisory Committee Recommends Against Approval of Oral Anticoagulant XARELTO® to Reduce the Risk of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

Low CV Event Rate Prompts Closure of Prasugrel Trial

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery

Axxess Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Five Years

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System

Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study

FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US

2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content